MACROGENICS, INC. LEASE AGREEMENTLease Agreement • March 3rd, 2015 • Macrogenics Inc • Pharmaceutical preparations
Contract Type FiledMarch 3rd, 2015 Company Industry
STOCK PURCHASE AGREEMENT By and Between JOHNSON & JOHNSON INNOVATION-JJDC, INC. AND MACROGENICS, INC. Dated as of December 19, 2014Stock Purchase Agreement • March 3rd, 2015 • Macrogenics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 3rd, 2015 Company Industry JurisdictionTHIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of December 19, 2014, by and between Johnson & Johnson Innovation-JJDC, Inc. (the “Investor”), a New Jersey corporation with its principal place of business at 410 George Street, New Brunswick, New Jersey 08901, and MacroGenics, Inc. (the “Company”), a Delaware corporation, with its principal place of business at 9640 Medical Center Drive, Rockville, MD 20850.
MacroGenics, Inc. Second Amendment to Lease AgreementLease Agreement • March 3rd, 2015 • Macrogenics Inc • Pharmaceutical preparations
Contract Type FiledMarch 3rd, 2015 Company IndustryThis Second Amendment to the Lease Agreement (“AMENDMENT”) is made and entered into this 6th day of November 2014, by and between RED GATE III LLC (“LANDLORD”) and MACROGENICS, INC. (“TENANT”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. INVESTOR AGREEMENT By and Between JOHNSON & JOHNSON INNOVATION-JJDC, INC. AND MACROGENICS, INC. Dated as of December...Investor Agreement • March 3rd, 2015 • Macrogenics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 3rd, 2015 Company Industry JurisdictionTHIS INVESTOR AGREEMENT (this “Agreement”) is made as of December 19, 2014, by and among Johnson & Johnson Innovation-JJDC, Inc., a New Jersey corporation with its principal place of business at 410 George Street, New Brunswick, New Jersey 08901 (“Investor”) and MacroGenics, Inc. (the “Company”), a Delaware corporation with its principal place of business at 9640 Medical Center Drive, Rockville, MD 20850.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN MACROGENICS, INC. AND JANSSEN BIOTECH, INC.Collaboration and License Agreement • March 3rd, 2015 • Macrogenics Inc • Pharmaceutical preparations
Contract Type FiledMarch 3rd, 2015 Company IndustryTHIS COLLABORATION AND LICENSE AGREEMENT (“Agreement”) is entered into as of December 19, 2014 (the “Execution Date”), by and between JANSSEN BIOTECH, INC., a Pennsylvania corporation, having its principal place of business at 800/850 Ridgeview Drive, Horsham, PA 19044 (hereinafter “Company”) and MACROGENICS, INC., a Delaware corporation having its principal place of business at 9640 Medical Center Drive, Rockville, MD 20850 (together with its Affiliates, “MacroGenics”). Company and MacroGenics are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
LEASELease • March 3rd, 2015 • Macrogenics Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 3rd, 2015 Company Industry JurisdictionTHIS LEASE (“Lease”) is made and entered into as of November 21, 2006, by and between BRITANNIA BIOTECH GATEWAY LIMITED PARTNERSHIP, a Delaware limited partnership (“Landlord”), and RAVEN BIOTECHNOLOGIES, INC., a Delaware corporation (“Tenant”).